Endocyte's Chief Science Officer just picked up 1,000 shares

Philip S Low, Endocyte's Chief Science Officer and a director of the company, recently acquired 1,000 shares of the company. The buys took place at $1.91 per share, on November 12, 2013. Low now owns 196,319 shares of the company. Low operates out of West Lafayette, IN. Some additional info was provided as follows:

This option is fully vested and immediately exercisable.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever Endocyte makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of changes in beneficial ownership of securities - April 11, 2014

   Auto Refresh

Feedback